Aardvark Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+51.2% +$40M
$117M
Current Assets↑+50.9% +$38M
$112M
Cash & Equivalents↓-23.7% -$15M
$47M
ST Investments↑+423.8% +$51M
$63M
Total Liabilities↑+95.6% +$5M
$11M
Current Liabilities↑+114.1% +$6M
$11M
Account Payables↓-9.8% -$226K
$2M
Stockholders Equity↑+295.1% +$161M
$107M
Retained Earnings↓-98.7% -$58M
$-116M
Operating Lease ROU Asset↓-51.7% -$380K
$355K
Operating Lease Liability↑+0.0% +$0
$441K